INTECH Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

INTECH Investment Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	9,704 -559	-5%	-$56.1K	0.01%	970
2026 Q1	$948K	Sell	10,263 -6,925	-40%	-$651K	0.01%	1042
2025 Q4	$1.36M	Hold	17,188	–	–	0.01%	951
2025 Q3	$1.26M	Sell	17,188 -3,651	-18%	-$232K	0.01%	1054
2025 Q2	$1.06M	Sell	20,839 -6,709	-24%	-$299K	0.01%	1159
2025 Q1	$1.24M	Buy	27,548 +4,398	+19%	+$207K	0.01%	1066
2024 Q4	$957K	Buy	23,150 +10,417	+82%	+$434K	0.01%	1180
2024 Q3	$497K	Buy	+12,733	New	+$508K	0.01%	1232

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's MIRM Position: Q2 2026 in Review

INTECH Investment Management reduced its Mirum Pharmaceuticals (MIRM) stake by 5.4% in Q2 2026, selling an estimated $56.1K and leaving 9,704 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #970.

INTECH Investment Management first reported a position in MIRM in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.36M in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

INTECH Investment Management held 9,704 shares of Mirum Pharmaceuticals worth $1.14M as of Q2 2026.
INTECH Investment Management sold 559 Mirum Pharmaceuticals shares in Q2 2026, an estimated $56.1K.
Mirum Pharmaceuticals made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #970 holding.
INTECH Investment Management first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Mirum Pharmaceuticals position peaked at $1.36M in Q4 2025.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.